Chargement en cours...
The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections
The continued rise in infections caused by extended-spectrum β-lactamase (ESBL)–producing pathogens is recognized globally as one of the most pressing concerns facing the healthcare community. Carbapenems are widely regarded as the antibiotics of choice for the treatment of ESBL-producing infections...
Enregistré dans:
| Publié dans: | Clin Infect Dis |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848369/ https://ncbi.nlm.nih.gov/pubmed/28362938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix034 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|